Equities

Syncom Formulations (India) Ltd

SYNCOMF:NSI

Syncom Formulations (India) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)22.71
  • Today's Change0.31 / 1.38%
  • Shares traded11.54m
  • 1 Year change+162.54%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,356745477
Total Receivables, Net1,137833676
Total Inventory247234195
Prepaid expenses3.313.49--
Other current assets, total4.851.6450
Total current assets2,7481,8171,398
Property, plant & equipment, net723688527
Goodwill, net------
Intangibles, net1.111.760.99
Long term investments5671,2491,131
Note receivable - long term5.194.983.38
Other long term assets2.061822
Total assets4,0473,7783,082
LIABILITIES
Accounts payable241204138
Accrued expenses6.265.85--
Notes payable/short-term debt725832578
Current portion long-term debt/capital leases------
Other current liabilities, total898967
Total current liabilities1,0621,132783
Total long term debt000
Total debt725832578
Deferred income tax504446
Minority interest------
Other liabilities, total534232
Total liabilities1,1651,218860
SHAREHOLDERS EQUITY
Common stock940940862
Additional paid-in capital244244--
Retained earnings (accumulated deficit)1,6981,3761,360
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2,8812,5602,222
Total liabilities & shareholders' equity4,0473,7783,082
Total common shares outstanding940940862
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.